Preventive
Effects of a Traditional Chinese Medicine (Sho-saiko-to) on
Endotoxin-Induced Cytotoxicity and Tumor Necrosis Factor-α
Production in J774A.1 Cells
|
|
Shuhei Sakaguchi1)
and Shinobu Furusawa2) |
|
1) First
Department of Hygienic Chemistry
2) Cancer Research Institute, Tohoku Pharmaceutical University |
|
(Received March 29, 2004)
(Accepted May 31, 2004)
|
|
|
Sho-saiko-to, one
of the most frequently prescribed Kampo medicines, is used
clinically to treat chronic hepatitis and has shown confirmed
clinical efficacy. The present study investigated whether
Sho-saiko-to can suppress cytotoxicity and tumor necrosis factor (TNF)-α
production in endotoxin-treated J774A.1 cells. Sho-saiko-to (10—20
μg/ml) did not affect the proliferation of J774A.1 cells, while a
high concentration (50 μg/ml) of Sho-saiko-to induced a slight
reduction in cell viability. Treatment with Sho-saiko-to (10—50 μg/ml)
significantly inhibited endotoxin (10 μg/ml)-induced cytotoxicity in
J774A.1 cells. In addition, Sho-saiko-to (20 μg/ml) suppressed TNF-α
production by endotoxin (1 μg/ml)-activated J774A.1 cells. These
findings suggest that the Kampo prescription Sho-saiko-to suppresses
cytotoxicity or TNF-α production in macrophages treated with
endotoxin and that it may be useful in improving septic shock
symptoms. Sho-saiko-to may therefore protect against some of the
various disturbances caused by endotoxins through its ability to
inhibit TNF-α production in septic shock. |
|
|